Mon 7/13/2020 12:59 ET
DJIA26545.89477.831.80%TELCO165.440.560.34%GOLD1809.3610.680.59%Shanghai3443.2960.951.77%
S&P 5003225.3540.961.27%BANKS335.102.750.82%OIL40.500.050.12%BITCOIN9266.4227.800.30%
NASDAQ10761.52146.361.36%PHARM607.2015.972.63%US/EU1.140.010.62%Futures3217.2538.611.20%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - YM BioSciences - YMI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  
From: crainiac (Rep: 4200)Date: 12/07/2012 12:27
Forum: YM BioSciences - Msg #3437Thread #673482622 (Rec: 0)
in here on the dip, two presentations at ASH 2012 on Sunday, links below:

Phase I/II Study of CYT387, a JAK1/JAK2 Inhibitor for the Treatment of Myelofibrosis

https://ash.confex.com/ash/2012/webprogram/Paper51560.html

Gene Expression Profiling within the Context of JAK Inhibitor Therapy for Myelofibrosis: Correlation with Treatment Effect and Anemia Response

https://ash.confex.com/ash/2012/webprogram/Paper51276.html

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreYMI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 2020- TheLion.com, Inc.